| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6337 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.7930 |
| P-glycoprotein Substrate | Substrate | 0.6654 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6608 |
| Inhibitor | 0.9129 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.6990 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4626 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.6158 |
| CYP450 2D6 Substrate | Substrate | 0.6080 |
| CYP450 3A4 Substrate | Substrate | 0.6762 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8166 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.8147 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8605 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5430 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.7754 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.7858 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8163 |
| Inhibitor | 0.6568 |
| AMES Toxicity | Non AMES toxic | 0.5748 |
| Carcinogens | Non-carcinogens | 0.6066 |
| Fish Toxicity | High FHMT | 0.9953 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8659 |
| Honey Bee Toxicity | Low HBT | 0.6892 |
| Biodegradation | Not ready biodegradable | 0.8723 |
| Acute Oral Toxicity | III | 0.5080 |
| Carcinogenicity (Three-class) | Non-required | 0.6100 |